acute kidney injury and chronic kidney disease - Nursing Case Study
Pathophysiology
• Primary mechanism (Acute Kidney Injury): Sudden decrease in renal blood flow leads to reduced glomerular filtration rate (GFR), causing accumulation of waste products like creatinine and urea, potentially resulting in oliguria or anuria.
• Primary mechanism (Chronic Kidney Disease): Gradual loss of nephrons due to prolonged hypertension or diabetes leads to compensatory hyperfiltration in remaining nephrons, eventually causing nephron damage and decreased GFR.
• Secondary mechanism (Both): Inflammatory processes and oxidative stress further damage renal tissues, exacerbating the decline in kidney function.
• Key complication: Metabolic imbalances, such as hyperkalemia and metabolic acidosis, arise due to impaired renal excretion, impacting cardiac and systemic health.
Patient Profile
Demographics:
64-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Stage 3 Chronic Kidney Disease
• Current medications: Lisinopril, Metformin, Amlodipine, Atorvastatin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing fatigue and swelling in legs
• Key symptoms: Reduced urine output, shortness of breath, nausea
• Vital signs: Blood pressure 160/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 37.4°C, oxygen saturation 92% on room air
Section 1
Initial Assessment Findings:
Upon initial assessment, the patient exhibited signs consistent with worsening renal function and possible acute kidney injury superimposed on chronic kidney disease. Physical examination revealed pitting edema in the lower extremities, indicative of fluid retention. Auscultation of the lungs disclosed bilateral crackles, suggesting pulmonary congestion likely due to fluid overload. The patient's skin appeared pale and slightly diaphoretic, and he reported experiencing persistent nausea and a decreased appetite over the past week.
Laboratory results showed a significant increase in serum creatinine to 3.2 mg/dL (baseline 1.8 mg/dL) and blood urea nitrogen (BUN) to 60 mg/dL, confirming the decline in renal function. Electrolyte imbalances were evident, with a potassium level of 5.8 mmol/L, posing a risk for cardiac dysrhythmias, and a bicarbonate level of 18 mmol/L, indicating metabolic acidosis. The patient's hemoglobin was 10.2 g/dL, suggesting mild anemia, which could contribute to his fatigue. Urinalysis revealed proteinuria, further supporting the diagnosis of deteriorating kidney function.
These findings necessitate prompt intervention to address fluid overload, correct metabolic imbalances, and stabilize the patient's condition. Initiating a low-sodium diet, adjusting antihypertensive medications, and considering diuretic therapy are crucial steps. Further diagnostic evaluation, including renal ultrasound and possibly a nephrology consult, will be essential to determine the underlying cause of the acute deterioration and guide long-term management strategies. As the clinical team evaluates the next steps, ongoing monitoring of the patient's hemodynamic status and lab values will be critical to assessing the effectiveness of interventions and preventing further complications.
Section 2
Change in Patient Status:
Following the initial interventions, the patient's condition showed signs of temporary stabilization. Diuretic therapy with intravenous furosemide was initiated to address the fluid overload, resulting in a reduction of peripheral edema and improvement in respiratory status, as evidenced by diminished crackles upon lung auscultation. A low-sodium diet was implemented, and adjustments were made to the patient's antihypertensive regimen to better control blood pressure, which now reads at 148/92 mmHg. However, despite these efforts, the patient began to exhibit new symptoms indicative of further complications.
Over the next 48 hours, the patient developed increasing fatigue and confusion, raising concerns about worsening metabolic derangements. Repeat laboratory tests revealed a further increase in serum creatinine to 3.8 mg/dL and BUN to 75 mg/dL, suggesting persistent renal dysfunction. The potassium level, despite initial diuretic therapy, had risen to 6.2 mmol/L, heightening the risk for cardiac complications. The electrocardiogram (ECG) displayed peaked T waves, consistent with hyperkalemia. Additionally, the patient's bicarbonate level decreased to 16 mmol/L, indicating worsening metabolic acidosis, while the hemoglobin dropped further to 9.8 g/dL, exacerbating his anemia.
These developments necessitate immediate clinical reasoning to prevent severe complications. The clinical team must consider the potential need for renal replacement therapy, such as dialysis, to manage the critical electrolyte imbalances and acidosis. Ensuring cardiac stability through continuous cardiac monitoring and possibly administering medications like calcium gluconate or insulin with glucose to counteract hyperkalemia will be essential. Further nephrology consultation is crucial to reassess the treatment plan and explore underlying causes, such as medication toxicity or an undiagnosed systemic condition, contributing to the deterioration in renal function. The focus will be on stabilizing the patient's condition while continuing to investigate reversible factors impacting his kidney health.
Section 3
New Complications:
In the subsequent 24 hours, the patient's condition began to deteriorate further, presenting with new complications that demanded urgent attention. The patient developed increasing shortness of breath and chest discomfort, prompting immediate reassessment of his cardiovascular status. Vital signs revealed a heart rate of 112 bpm and a blood pressure of 158/98 mmHg, indicating a possible compensatory response to hypoxia or worsening fluid overload. Oxygen saturation had decreased to 88% on room air, necessitating supplemental oxygen therapy to maintain adequate oxygenation. Auscultation of the lungs revealed coarse crackles bilaterally, now extending to the mid-lung zones, suggesting pulmonary congestion secondary to fluid overload.
The patient's neurological status also declined, with heightened confusion and agitation noted during nurse assessments. These changes raised concerns about the potential progression of uremic encephalopathy due to significant azotemia. Repeat lab tests confirmed that the serum creatinine had climbed to 4.1 mg/dL, and BUN soared to 82 mg/dL, reinforcing the need for immediate intervention. The potassium level remained critically elevated at 6.4 mmol/L, despite measures taken to address hyperkalemia, and the ECG continued to show peaked T waves, posing a persistent risk for arrhythmias.
Recognizing the urgency of the situation, the clinical team initiated an intensive treatment protocol to stabilize the patient's condition and prevent further complications. A decision was made to commence emergent dialysis to address the severe electrolyte imbalances and remove excess fluid. In parallel, calcium gluconate was administered intravenously to protect cardiac function, and an insulin-glucose infusion was started to facilitate intracellular potassium shift. Continuous cardiac monitoring was maintained to detect any arrhythmogenic events promptly. These interventions aimed to stabilize the patient while providing a window of opportunity for the nephrology team to further evaluate and adjust the overall management plan, including reassessment of the patient's medication regimen and exploration of potential underlying causes of the acute deterioration.
Section 4
Response to Interventions
Following the initiation of emergent dialysis and adjunctive therapies, the patient's condition began to show some signs of stabilization. Within hours, the supplemental oxygen managed to increase oxygen saturation to 92%, and the patient reported a slight reduction in chest discomfort, suggesting an initial positive response to the fluid removal and electrolyte management. Repeat lab tests showed a decline in serum potassium levels to 5.2 mmol/L, indicating that efforts to shift potassium intracellularly were effective. Heart rate decreased to 98 bpm, and blood pressure stabilized at 145/85 mmHg, reflecting improved hemodynamic status.
However, the patient's neurological status remained a concern. Although the agitation subsided somewhat, the patient continued to exhibit confusion, raising questions about the adequacy of uremic toxin clearance and the need for further dialysis sessions. The clinical team decided to continue close neurological monitoring and planned for sequential dialysis treatments, taking into account the evolving renal function and potential for ongoing electrolyte derangements. Continuous cardiac monitoring showed an absence of new arrhythmias, though vigilance was maintained due to the prior hyperkalemia.
The patient's improvement in respiratory and cardiovascular parameters provided a window to reassess the overall treatment plan. This included a detailed review of the medication regimen, particularly focusing on potential nephrotoxic agents and medications contributing to fluid overload. The nephrology team also explored underlying causes of the acute deterioration, considering factors such as medication non-compliance, dietary indiscretion, or concurrent infections. As the clinical picture evolved, the team remained poised to adjust the therapeutic approach, aiming to optimize renal recovery while minimizing the risk of further complications.
Section 5
As the clinical team continued to monitor the patient, new diagnostic results provided further insights into the patient's condition. A follow-up renal ultrasound revealed moderate hydronephrosis, suggesting an obstructive component that could have contributed to the acute kidney injury. This finding prompted the team to consider potential urological causes, such as nephrolithiasis or ureteral stricture, which may require surgical intervention or stenting to alleviate the obstruction and prevent further renal damage. Additionally, a urinalysis showed significant proteinuria and microscopic hematuria, raising the possibility of an underlying glomerulonephritis that could be exacerbating the chronic kidney disease and complicating recovery.
Parallel to these findings, the patient's laboratory results indicated a persistent mild metabolic acidosis with a serum bicarbonate level of 18 mmol/L, necessitating careful management to prevent further acid-base imbalance. The nephrology team discussed the need for adjusting the dialysis prescription to enhance clearance of metabolic waste products while also considering the initiation of oral bicarbonate supplementation. Meanwhile, the patient's hemoglobin level dropped to 8.9 g/dL, suggesting anemia of chronic disease, which could contribute to the patient's ongoing fatigue and confusion. This anemia warranted further evaluation for potential erythropoietin therapy, given the compromised renal function.
These diagnostic insights underscored the complexity of the patient's condition, necessitating a multidisciplinary approach to address the interplay of acute and chronic renal issues, electrolyte imbalances, and systemic complications. The team emphasized the importance of maintaining a dynamic treatment plan, incorporating regular reassessment of renal function, and being vigilant for signs of potential new complications, such as infections or further cardiovascular instability. Through collaborative clinical reasoning, the team aimed to optimize the patient's recovery trajectory while preparing for potential transitions in care, including long-term management strategies for chronic kidney disease.